• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.

作者信息

Cashin Peter H, Söderström Maria, Blom Kristin, Artursson Sara, Andersson Claes, Larsson Rolf, Nygren Peter

机构信息

Department of Surgical Sciences, Section of Colorectal Surgery, Uppsala University, Uppsala, Sweden.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

Br J Surg. 2023 Aug 11;110(9):1080-1083. doi: 10.1093/bjs/znad066.

DOI:10.1093/bjs/znad066
PMID:36918737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10416678/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f2/10416678/0b43e39b68dc/znad066f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f2/10416678/20f898fb93ec/znad066f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f2/10416678/0b43e39b68dc/znad066f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f2/10416678/20f898fb93ec/znad066f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f2/10416678/0b43e39b68dc/znad066f2.jpg

相似文献

1
Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.结直肠癌腹膜转移化疗敏感性的体外评估
Br J Surg. 2023 Aug 11;110(9):1080-1083. doi: 10.1093/bjs/znad066.
2
Bi-directional chemotherapy for peritoneal metastases.用于腹膜转移的双向化疗。
Br J Surg. 2023 May 16;110(6):627-628. doi: 10.1093/bjs/znad061.
3
Protocols versus practice in the management of colorectal peritoneal metastases.结直肠腹膜转移瘤管理中的方案与实践
J Surg Oncol. 2022 Jun;125(8):1200-1201. doi: 10.1002/jso.26848. Epub 2022 Mar 15.
4
Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases.双药与三药全身化疗用于治疗伴有腹膜转移的高级别阑尾腺癌
J Gastrointest Surg. 2023 Nov;27(11):2560-2562. doi: 10.1007/s11605-023-05747-0. Epub 2023 Jun 12.
5
Deep Epigastric Lymph Nodes Implication in Patients' Recurrence Pattern After Cytoreductive Surgery in Colorectal Peritoneal Metastases.腹主动脉旁淋巴结在结直肠癌腹膜转移细胞减灭术后患者复发模式中的意义
J Gastrointest Surg. 2022 Jun;26(6):1314-1317. doi: 10.1007/s11605-021-05218-4. Epub 2022 Jan 8.
6
ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：结直肠癌腹膜转移的发病时间并非是经细胞减灭术联合腹腔内热化疗后生存结局的独立预测因素。
Ann Surg Oncol. 2022 Oct;29(11):6577-6578. doi: 10.1245/s10434-022-11842-4. Epub 2022 Apr 29.
7
ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.ASO作者反思：热灌注化疗的免疫原性变化可通过免疫疗法进一步利用，以治疗结直肠癌的腹膜转移。
Ann Surg Oncol. 2023 May;30(5):2664-2665. doi: 10.1245/s10434-023-13254-4. Epub 2023 Feb 17.
8
Editorial in response to "Peritoneal metastases in elderly patients with colorectal cancer".针对“老年结直肠癌患者的腹膜转移”的社论
Eur J Surg Oncol. 2022 Dec;48(12):2353. doi: 10.1016/j.ejso.2022.08.015. Epub 2022 Aug 23.
9
Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.结直肠癌腹膜癌转移的热灌注腹腔化疗治疗
ANZ J Surg. 2017 Sep;87(9):665-670. doi: 10.1111/ans.14077. Epub 2017 Jun 30.
10
Adoption of cytoreductive surgery in the management of peritoneal malignancies-Global trends.腹腔恶性肿瘤细胞减灭术的应用-全球趋势。
J Surg Oncol. 2023 Nov;128(6):1021-1031. doi: 10.1002/jso.27448.

引用本文的文献

1
Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer.斑马鱼替身试验预测结直肠癌患者对化疗的临床反应。
Nat Commun. 2024 Jun 5;15(1):4771. doi: 10.1038/s41467-024-49051-0.
2
Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.高温腹腔内化疗治疗结直肠癌的疗效：一项 I 期和 III 期开放标签随机对照注册临床试验方案。
PLoS One. 2024 Mar 4;19(3):e0294018. doi: 10.1371/journal.pone.0294018. eCollection 2024.

本文引用的文献

1
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.细胞减灭术联合腹腔热灌注化疗与单纯细胞减灭术治疗结直肠腹膜转移瘤（PRODIGE 7）：一项多中心、随机、开放标签、3 期临床试验。
Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18.
2
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin.接受 FOLFOX 或 CAPOX 治疗的结直肠癌患者的癌细胞对奥沙利铂有耐药性。
Eur J Surg Oncol. 2021 Apr;47(4):738-742. doi: 10.1016/j.ejso.2020.09.017. Epub 2020 Sep 19.
3
Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
结直肠腹膜转移来源的类器官作为提高腹腔内热化疗的平台。
Br J Surg. 2019 Sep;106(10):1404-1414. doi: 10.1002/bjs.11206. Epub 2019 Jun 14.
4
Organoids - Preclinical Models of Human Disease.类器官——人类疾病的临床前模型
N Engl J Med. 2019 Feb 7;380(6):569-579. doi: 10.1056/NEJMra1806175.
5
Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis.体外药敏试验预测个体化癌症化疗的价值：荟萃分析。
SLAS Technol. 2017 Jun;22(3):306-314. doi: 10.1177/2472630316686297. Epub 2017 Jan 31.
6
Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.细胞减灭术及腹腔内化疗与全身化疗治疗结直肠癌腹膜转移的随机对照试验
Eur J Cancer. 2016 Jan;53:155-62. doi: 10.1016/j.ejca.2015.09.017. Epub 2016 Jan 2.
7
Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy.患者肿瘤细胞中药物活性的体外评估作为个性化癌症治疗的基础
J Lab Autom. 2016 Feb;21(1):178-87. doi: 10.1177/2211068215598117. Epub 2015 Aug 5.
8
Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.患者接受细胞减灭术后腹腔内加温化疗奥沙利铂后，散发性腹膜癌患者腹腔、血浆超滤和蛋白结合奥沙利铂浓度的群体药代动力学：奥沙利铂暴露与血小板减少症的相关性。
Cancer Chemother Pharmacol. 2014 Sep;74(3):571-82. doi: 10.1007/s00280-014-2525-6. Epub 2014 Jul 23.
9
Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate.细胞减灭术和腹腔内热化疗治疗结直肠腹膜转移：大容量疾病和治愈率的队列分析。
J Surg Oncol. 2014 Aug;110(2):203-6. doi: 10.1002/jso.23610. Epub 2014 May 21.
10
Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.细胞毒性药物在腹膜癌病患者样本中的体外活性，特别关注结直肠癌
BMC Cancer. 2013 Sep 24;13:435. doi: 10.1186/1471-2407-13-435.